Our Cancer Risk Screening Assessment Package offers a proactive approach to health, incorporating a series of blood tests designed to detect potential signs of cancer and other health conditions. These tests analyze tumor markers like CEA, CA-19-9, AFP, and BHCG, alongside LDH to identify cellular abnormalities indicative of cancer. Hormone levels, including PSA and Parathyroid Hormone, are assessed for their influence on cancer risk. Additionally, urine routine tests and a Complete Blood Count (CBC) provide insights into kidney, bladder, and blood-related cancers. These tests collectively offer a comprehensive evaluation, enabling early detection and intervention when needed, empowering individuals to take control of their health.